Last 3 exams SAQs Flashcards
(143 cards)
5 mechanisms for pathogenesis of PET and clinical sequalae
Failure of trophoblastic invasion into maternal spiral arteries prior to 20 weeks causing ischemia IUGR
Damaged placenta releases inflammatory factors into maternal circulation which causes endothelial dysfunction and loss of water into intravascular space OEDEMA
Vasoconstriction of blood vessels due to damaged endothelial cells does not accommodate extra cardiac output HYPERTENSION
Endothelial damage at the kidney causes protein to escape at the glomerular capillaries PROTEINURIA
Maternal plasma volume contraction due to loss of water from intravascular space and activation of clotting factors due to endothelial damage VTE
6 points to pre-conception counselling for previous PET
Educate the woman at an increased risk in pregnancy: Recurrence 30% <32weeks 15% >32weeks Increased IUGR and GHTN Review for any ongoing issues: Hypertension (stop ace-i) Diabetes Should have been screened for APLS Baseline U&Es and uPCR Management to reduce recurrence: Aspirin & calcium Antenatal care model: Uterine artery doppler Growth scans (from 24 weeks if notching on uterine) Regular BP urine checks Discuss long term sequalae of PET: Cardiovascular disease, hypertension, T2DM & VTE. Improve other risk factors such as weight and alcohol consumption. General pre-conception: Folic acid, iodine, vaccinations, smear tests & contracpetion
Name CLASP research design
Double blind RCT
Name intervention in CLASP
Low dose aspirin 60mg daily from 12-32 weeks vs placebo
State level the level of significance for the findings of CLASP
Reduction in proteinuric PET by 12% overall 22% <20weeks. Not statistically significant.
1 reason for smaller effect of aspirin found in CLASP
Heterogenous participant including those high risk and low risk for PET and using aspirin for treatment and prevention purposes. This may have diluted effect of aspirin in high risk women.
What is sequential genetic carrier testing and advantages and disadvantages
One member of a couple is tested for heritible conditions first and then if positive the other partner is screened.
Advantages:
Less screening, allows for cascade screening of effected partner’s family.
Disadvantages:
More referrals to genetic counsellors, time delay may cause anxiety while 2nd person’s screen is completed.
What is combined couple genetic carrier testing the advantages and disadvantages
Both members of the couple are tested simultaneously
Advantages:
Quick
Disadvantages:
Only gives assessment for them as a couple if changes partners no longer relevant.
Principles of informed consent
Information being provided to the couple in a form, language and manner that is acceptable to the couple and allows them to understand.
Given all options and the advantages and disadvantages for each.
Person competent to understand the information and weigh up pros and cons.
Options if a heritable genetic condition is discovered in a couple
Spontaneous conception and test neonate Spontaneous conception and invasive prenatal testing in pregnancy. IVF and preimplantation genetic testing IVF with donor sperm or egg Adoption or remaining childless
Carrier frequencies for 3 common conditions
Fragile X premutation 1:332
Spinal muscular dystrophy 1:50
Cystic fibrosis 1:25-35
Contraindications to VBAC
Previous classical c-section
Uterine rupture at last c-section
J or T incision
Previous surgery that breeched cavity e.g. myomectomy
Short interpregnancy interval <12 months.
1 benefit and 4 risks to neonate from VBAC
Benefit: Reduction in RDS Risks: Term stillbirth Hypoxia in labour Birth injury Meconium liquor and aspiration
Features suggestive of uterine rupture
Abnormal CTG Abdominal pain beyond contraction Acute onset of scar tenderness PV Bleeding Heamaturia Cessation of previously good uterine activity Maternal shock Loss of station of presenting part
3 most likely causes of primary PPH
Uterine atony
Genital tract trauma
Retained tissue
5 management principles for PPH
RECOGNITION e.g. Weigh loss
COMMUNICATION e.g. Call for help
RESUSCITATION e.g. ABCs
MONITORING AND INVESTIAGTIONS e.g. Observations
MANAGEMENT e.g. early transfer to OT if bleeding continues
2 surgical interventions appropriate for uncontrolled PPH
Bakri
B-Lynch or Hayman suture
Hysterectomy
MOA of tranexamic acid
Prevents conversion of plasminogen to plasmin. Plasmin is required to breakdown fibrin so it prevents the breakdown of clots.
Inclusion criteria from WOMAN trial
Any woman >16 years old having PPH defined as >500ml in vaginal birth and >1000ml in C-section
Primary outcome in WOMAN trial
The need for hysterectomy
1 limitation of WOMAN trial
Decision for TXA often happened simultaneously with hysterectomy especially in low resource settings meaning the primary outcome is likely less statistically significant than it should be.
1 strength of WOMAN trial
large numbers 20,000, randomised placebo controlled, double blind study
Differentials of acute abdomen in pregnancy
Gynae: torsion, PID Obstetric: uterine rupture, abruption GI tract: Appendix, cholecystitis Genitourinary: Pyleonephritis, kidney stones Vascular: ruptured aortic aneurysm.
What is risk of loss in appendicitis
Generally 1.5%
Peritionitis 6%
Perforated 35%